Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Immuneering Corp (IMRX) AI Forecast

Our AI analyzed Immuneering Corp. Create a free account to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$IMRX Neutral Signal Full forecast available
Sign Up Free

Immuneering Corp (IMRX) Stock Forecast 2025

Immuneering Corp (IMRX) AI Stock Price Forecast & Investment Analysis

Immuneering Corp Stock Price Chart and Technical Analysis

Loading chart...

Immuneering Corp (IMRX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Immuneering Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on June 18, 2026, 7:39 a.m. (UTC)

Immuneering Corp Investment Summary

When evaluating whether Immuneering Corp (IMRX) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Immuneering Corp (IMRX) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $285 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Immuneering Corp's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Immuneering Corp along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Immuneering Corp is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Immuneering Corp

Sign Up Free
Corporate Identity

Immuneering Corp (Stock Symbol: IMRX) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Immuneering Corp's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Immuneering Corp...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Immuneering Corp...

Unlock Full Company Profile

Get complete details about Immuneering Corp

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Immuneering Corp...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Immuneering Corp...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Immuneering Corp...

Unlock Financial Analysis

Get complete financial metrics for Immuneering Corp

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Immuneering Corp's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Immuneering Corp strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Immuneering Corp competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-50 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Margin & Pricing Power Analysis

The company maintains a 48.3% gross margin indicating healthy pricing power relative to direct production costs. This margin level suggests the company has successfully differentiated its products or services, allowing it to command prices meaningfully above input costs. Maintaining these margins requires ongoing investment in brand, technology, or other differentiating factors.

Operating margin of -1010.3% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Financial Strength & Leverage

Current ratio of 32.45 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Immuneering Corp (IMRX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Immuneering Corp stock analysis.

Deep dive into Immuneering Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Immuneering Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Immuneering Corp:

P/B Ratio 1.38x
Market Cap $285M
EPS $-11.48
Book Value/Share $3.19
FCF/Share $-0.77
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Immuneering Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Immuneering Corp: An ROE of -27.5% indicates room for improvement in shareholder value creation.

ROE -27.5%
ROA -26.5%
ROIC -27.1%
Gross Margin 48.3%
Operating Margin -1010.3%
Net Margin -1009.6%
EBT Margin -1010.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Immuneering Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Immuneering Corp: A current ratio of 32.45 indicates strong liquidity.

Current Ratio 32.45x
D/E Ratio 0.04x
Financial Leverage 1.04x
Working Capital $156M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Immuneering Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Immuneering Corp: Free cash flow of $-50M indicates cash challenges that need attention.

Operating Cash Flow -$50M
Free Cash Flow -$50M
Capital Spending $400K
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Immuneering Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Immuneering Corp:

Payables Period 182 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Immuneering Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Immuneering Corp:

Income Statement
Operating Income -$56M
Net Income -$56M
R&D Expense $50M
Cost of Goods Sold $3M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 161%
Cash & Short-term Investments 47%
Total Liabilities 8%
Short-term Debt 4%
Dividend & Shareholder Information
Shares Outstanding 65M
Growth Metrics (YoY)
Net Income Growth -1009.6%
EPS Growth -260.3%

Latest Immuneering Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Immuneering Corp (IMRX) stock price and investment outlook.

source: CNN

View Immuneering Corp. Class A IMRX stock quote prices, financial information, real-time forecasts, and company news from CNN.

source: BioWorld

Having nailed down alignment with the U.S. FDA in December on a phase III trial that will start in the middle of this year, Immuneering Corp. updated the overall survival and safety data from an ...

More news available

Sign up free to read all 6 news articles and stay updated on market developments.

Sign Up Free to Read More

Immuneering Corp Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Immuneering Corp against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $83M x 1.0x
Abbvie Inc. ABBV ██% $391.54B 107.7x x
Abcellera Biologics Inc. ABCL ██% $1.65B x 1.8x
Abeona Therapeutics Inc. ABEO ██% $321M 4.9x 2.2x
Abbott Laboratories ABT ██% $154.08B 24.6x 3.0x
Arbutus Biopharma Corp ABUS ██% $872M 5.4x 3.4x
Abvc Biopharma, Inc. ABVC ██% $35M x 3.3x
Abivax S.A. ABVX ██% $7.87B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.70B 9.8x 3.0x
Adicet Bio, Inc. ACET ██% $76M x 0.5x
Aclaris Therapeutics, Inc. ACRS ██% $617M x 4.3x
Acrivon Therapeutics, Inc. ACRV ██% $59M x 0.6x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $4M x x
Acurx Pharmaceuticals, Inc. ACXP ██% $7M x 0.9x
Adagene Inc. ADAG ██% $233M x 6.2x
Adc Therapeutics Sa ADCT ██% $141M x x
Adial Pharmaceuticals, Inc. ADIL ██% $6M x 1.6x
Aditxt, Inc. ADTX ██% $0.00M x x
Addex Therapeutics Ltd. ADXN ██% $8M x x
Aeon Biopharma, Inc. AEON ██% $17M x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.96B x 1.8x
Akebia Therapeutics, Inc. AKBA ██% $273M x 10.0x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $19M x 1.3x
Aldeyra Therapeutics, Inc. ALDX ██% $110M x 2.6x
Alkermes Plc. ALKS ██% $7.41B 48.5x 4.2x
Allarity Therapeutics, Inc. ALLR ██% $21M x 3.1x
Alumis Inc. ALMS ██% $2.88B x 5.1x
Alnylam Pharmaceuticals, Inc. ALNY ██% $37.43B 119.3x 47.4x
Altimmune, Inc. ALT ██% $513M x 1.8x
Alx Oncology Holdings Inc ALXO ██% $195M x 1.3x
Alzamend Neuro, Inc. ALZN ██% $5M x 2.2x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.69B x 6.2x
Amphastar Pharmaceuticals, Inc. AMPH ██% $866M 10.9x 1.1x
Amarin Corp Plc\Uk AMRN ██% $331M x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $5.14B 42.1x x
Anaptysbio, Inc ANAB ██% $1.65B x 129.3x
Anebulo Pharmaceuticals, Inc. ANEB ██% $19M x 2.4x
Ani Pharmaceuticals Inc ANIP ██% $1.68B 18.3x 3.0x
Anixa Biosciences Inc ANIX ██% $91M x 6.3x
Annexon, Inc. ANNX ██% $753M x 3.7x
Alto Neuroscience, Inc. ANRO ██% $764M x 3.1x
An2 Therapeutics, Inc. ANTX ██% $176M x 2.2x
Annovis Bio, Inc. ANVS ██% $74M x 23.7x
Apollomics Inc. APLM ██% $31M x x
Apellis Pharmaceuticals, Inc. APLS ██% $5.25B 39.4x 12.7x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $9M x 0.2x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $20M x 0.2x
Aptevo Therapeutics Inc. APVO ██% $6M x 0.5x
Aquestive Therapeutics, Inc. AQST ██% $551M x x
Arcturus Therapeutics Holdings Inc. ARCT ██% $209M x 1.1x
Ardelyx, Inc. ARDX ██% $1.44B x 9.7x
Arcutis Biotherapeutics, Inc. ARQT ██% $3.28B x 17.3x
Artelo Biosciences, Inc. ARTL ██% $4M x 0.7x
Arvinas, Inc. ARVN ██% $495M x 1.3x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $11.39B x 18.6x
Aspire Biopharma Holdings, Inc. ASBP ██% $8M x 2.1x
Assembly Biosciences, Inc. ASMB ██% $479M x 2.4x
Ascendis Pharma A/S ASND ██% $14.33B x x
Assertio Holdings, Inc. ASRT ██% $151M x 2.0x
Atai Beckley N.V. ATAI ██% $1.50B x 9.4x
Alterity Therapeutics Ltd ATHE ██% $93M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $32M x 13.9x
Atossa Therapeutics, Inc. ATOS ██% $20M x 0.7x
Avenue Therapeutics, Inc. ATXI ██% $890K x 0.7x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.11B 7.1x 3.7x
Arrivent Biopharma, Inc. AVBP ██% $1.42B x 4.4x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $347M x 1.5x
Avalo Therapeutics, Inc. AVTX ██% $810M x 11.9x
Axim Biotechnologies, Inc. AXIM ██% $2M x x
Axsome Therapeutics, Inc. AXSM ██% $12.97B x 237.5x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $3M x 0.3x
Bridgebio Pharma, Inc. BBIO ██% $13.19B x x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $615M x 1.7x
Bicara Therapeutics Inc. BCAX ██% $1.50B x 2.9x
Briacell Therapeutics Corp. BCTX ██% $24M x 1.0x
Bicycle Therapeutics Plc BCYC ██% $282M x 0.5x
Bioadaptives, Inc. BDPT ██% $40K x x
Biodexa Pharmaceuticals Plc BDRX ██% $510K x x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $13M x 2.7x
Biofrontera Inc. BFRI ██% $12M x 1.9x
Bio Green Med Solution, Inc. BGMS ██% $5M x 0.7x
Bausch Health Companies Inc. BHC ██% $1.78B x x
Bioharvest Sciences Inc. BHST ██% $74M x 2.9x
Biohaven Ltd. BHVN ██% $1.22B -4.6x 23.4x
Bioage Labs, Inc. BIOA ██% $887M x 2.3x
Bio Essence Corp BIOE ██% $12M 9.1x x
Biovie Inc. BIVI ██% $14M x 0.9x
Bioxytran, Inc BIXT ██% $3M x x
Biolinerx Ltd. BLRX ██% $14M x x
Belite Bio, Inc BLTE ██% $5.84B x 7.6x
Biomea Fusion, Inc. BMEA ██% $87M x 4.6x
Biomarin Pharmaceutical Inc BMRN ██% $10.63B 39.6x 1.7x
Bristol Myers Squibb Co BMY ██% $112.66B 15.5x 5.6x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $405M x 2.2x
Boundless Bio, Inc. BOLD ██% $31M x 0.4x
Bolt Biotherapeutics, Inc. BOLT ██% $8M x 0.4x
Bio-Path Holdings, Inc. BPTH ██% $2M x x
Bioquest Corp BQST ██% $2M x x
Barinthus Biotherapeutics Plc. BRNS ██% $29M x 0.4x
Bespoke Extracts, Inc. BSPK ██% $2M x x
Bioxcel Therapeutics, Inc. BTAI ██% $37M x x
Beyondspring Inc. BYSI ██% $65M x x
Calcimedica, Inc. CALC ██% $13M x x
Camp4 Therapeutics Corp CAMP ██% $208M -0.1x 4.4x
Can-Fite Biopharma Ltd. CANF ██% $6M x 1.2x
Capricor Therapeutics, Inc. CAPR ██% $1.61B x 5.8x
Carisma Therapeutics Inc. CARM ██% $0.00M 0.0x x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $340M x 1.0x
Gyre Therapeutics, Inc. CBIO ██% $502M x 5.0x
Cdt Equity Inc. CDT ██% $3M x 0.8x
Cingulate Inc. CING ██% $69M x 3.7x
Cell Source, Inc. CLCS ██% $56M x x
Clene Inc. CLNN ██% $70M x x
Cellectar Biosciences, Inc. CLRB ██% $20M x 5.9x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Clearside Biomedical, Inc. CLSDQ ██% $580K x x
Climb Bio, Inc. CLYM ██% $649M x 4.4x
Chemomab Therapeutics Ltd. CMMB ██% $11M x 0.9x
Clearmind Medicine Inc. CMND ██% $5M x x
Compass Pathways Plc CMPS ██% $1.61B x 4.9x
Cnbx Pharmaceuticals Inc. CNBX ██% $120K x x
Cns Pharmaceuticals, Inc. CNSP ██% $7M x 93.6x
Centessa Pharmaceuticals Plc CNTA ██% $6.17B x 12.7x
Connect Biopharma Holdings Ltd CNTB ██% $130M x 3.1x
Canton Strategic Holdings, Inc. CNTN ██% $247M x 0.5x
Context Therapeutics Inc. CNTX ██% $55M x 1.1x
Cocrystal Pharma, Inc. COCP ██% $13M x 3.3x
Cogent Biosciences, Inc. COGT ██% $5.75B x 9.5x
Collegium Pharmaceutical, Inc COLL ██% $1.09B 14.6x 3.5x
Corcept Therapeutics Inc CORT ██% $8.54B 180.3x 13.4x
Coya Therapeutics, Inc. COYA ██% $118M x 2.4x
China Pharma Holdings, Inc. CPHI ██% $34M x 0.9x
Cumberland Pharmaceuticals Inc CPIX ██% $84M x 3.9x
Cannapharmarx, Inc. CPMD ██% $2M x x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.84B 17.3x 3.8x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $143M x 1.1x
Cormedix Inc. CRMD ██% $680M 3.8x 1.6x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.76B x 2.9x
Cervomed Inc. CRVO ██% $35M x 3.3x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.01B x 4.2x
Cytomx Therapeutics, Inc. CTMX ██% $644M x 2.0x
Contineum Therapeutics, Inc. CTNM ██% $454M x 1.8x
Citius Oncology, Inc. CTOR ██% $61M x 1.7x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Ctt Pharmaceutical Holdings, Inc. CTTH ██% $5M x 6.4x
Citius Pharmaceuticals, Inc. CTXR ██% $15M x 0.2x
Cue Biopharma, Inc. CUE ██% $112M x 5.2x
Curanex Pharmaceuticals Inc CURX ██% $10M x 1.2x
Cadrenal Therapeutics, Inc. CVKD ██% $10M x 5.3x
Cv Sciences, Inc. CVSI ██% $4M x 2.4x
Cyclerion Therapeutics, Inc. CYCN ██% $13M x 2.0x
Cytodyn Inc. CYDY ██% $371M x x
Cypherpunk Technologies Inc. CYPH ██% $81M x 1.0x
Cryoport, Inc. CYRX ██% $731M 9.2x 1.5x
Cytokinetics Inc CYTK ██% $10.61B x x
Dare Bioscience, Inc. DARE ██% $30M x 41.2x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.22B x 5.0x
Decoy Therapeutics Inc. DCOY ██% $3M x 0.8x
Journey Medical Corp DERM ██% $162M x 5.2x
Diamedica Therapeutics Inc. DMAC ██% $309M x 6.5x
Damora Therapeutics, Inc. DMRA ██% $1.32B x 2.6x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $4.47B x 3.7x
Dermata Therapeutics, Inc. DRMA ██% $5M x 0.8x
Bright Minds Biosciences Inc. DRUG ██% $584M x x
Design Therapeutics, Inc. DSGN ██% $745M x 3.4x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $50M x 0.6x
Dyne Therapeutics, Inc. DYN ██% $3.17B x 3.7x
Emergent Biosolutions Inc. EBS ██% $422M x 0.8x
Edesa Biotech, Inc. EDSA ██% $61M x 6.0x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $6M x 0.5x
Elanco Animal Health Inc ELAN ██% $11.68B x 1.8x
Eledon Pharmaceuticals, Inc. ELDN ██% $281M x 6.3x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $387M 14.1x 4.8x
Elicio Therapeutics, Inc. ELTX ██% $88M x x
Enliven Therapeutics, Inc. ELVN ██% $3.13B x 6.9x
Emmaus Life Sciences, Inc. EMMA ██% $700K x x
Enlivex Ltd. ENLV ██% $149M 0.1x 0.1x
Ensysce Biosciences, Inc. ENSC ██% $4M x x
Enanta Pharmaceuticals Inc ENTA ██% $367M x 3.2x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $5M x 1.0x
Evolus, Inc. EOLS ██% $444M x x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $411M x 5.0x
Equillium, Inc. EQ ██% $189M x 3.2x
Erasca, Inc. ERAS ██% $4.35B x 11.0x
Ernexa Therapeutics Inc. ERNA ██% $7M x 1.0x
Esperion Therapeutics, Inc. ESPR ██% $797M x x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $896M x 29.3x
Earth Science Tech, Inc. ETST ██% $50M 12.3x 8.7x
Evofem Biosciences, Inc. EVFM ██% $1M x x
Evommune, Inc. EVMN ██% $744M x 2.4x
Edgewise Therapeutics, Inc. EWTX ██% $3.74B x 7.6x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $102M 0.8x 0.6x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $4M x 1.6x
Forte Biosciences, Inc. FBRX ██% $360M x 8.6x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $238M x x
Filana Therapeutics, Inc. FLNA ██% $58M x 0.9x
Amicus Therapeutics, Inc. FOLD ██% $4.50B x 16.4x
Fulcrum Therapeutics, Inc. FULC ██% $233M x 0.7x
Galectin Therapeutics Inc GALT ██% $182M x x
Gain Therapeutics, Inc. GANX ██% $76M x 5.4x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $140K x x
Cytomed Therapeutics Ltd GDTC ██% $13M x x
Geron Corp GERN ██% $803M x 3.5x
Gh Research Plc GHRS ██% $1.35B x x
Galmed Pharmaceuticals Ltd. GLMD ██% $4M x 0.3x
Lakefront Biotherapeutics Nv GLPG ██% $1.85B x x
Greenwich Lifesciences, Inc. GLSI ██% $352M x 66.8x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $128M x 5.6x
Genprex, Inc. GNPX ██% $5M x 0.3x
Gossamer Bio, Inc. GOSS ██% $88M x x
Geovax Labs, Inc. GOVX ██% $6M x 12.5x
Structure Therapeutics Inc. GPCR ██% $3.20B x 2.2x
Grace Therapeutics, Inc. GRCE ██% $34M x 0.5x
Gri Bio, Inc. GRI ██% $4M x 0.4x
Galera Therapeutics, Inc. GRTX ██% $17M 0.1x 23.7x
Gsk Plc GSK ██% $104.50B x x
Gt Biopharma, Inc. GTBP ██% $17M x 2.2x
Gyre Therapeutics, Inc. GYRE ██% $555M x 5.5x
Hutchmed (China) Ltd HCM ██% $1.74B 1.9x 1.4x
Hcw Biologics Inc. HCWB ██% $8M x 1.4x
Cybin Inc. HELP ██% $229M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $2M x 1.3x
Vyome Holdings, Inc HIND ██% $15M x 2.3x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $14M x 0.4x
Rocket One Inc. HOTH ██% $42M x 10.2x
Werewolf Therapeutics, Inc. HOWL ██% $17M x 1.4x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.95B 13.4x 2.2x
Heron Therapeutics, Inc. /De/ HRTX ██% $74M x 8.1x
Hst Global, Inc. HSTC ██% $99M x 79.9x
Tuhura Biosciences, Inc./Nv HURA ██% $141M x 6.1x
Mindwalk Holdings Corp. HYFT ██% $70M x x
Hyperion Defi, Inc. HYPD ██% $54M x 0.9x
Ibio, Inc. IBIO ██% $79M x 1.0x
Impact Biomedical Inc. IBO ██% $62M x 5.4x
Ideaya Biosciences, Inc. IDYA ██% $2.75B x 2.9x
Inflarx N.V. IFRX ██% $268M x x
Igc Pharma, Inc. IGC ██% $28M x 4.5x
Immutep Ltd IMMP ██% $55M x x
Immix Biopharma, Inc. IMMX ██% $650M x 7.7x
Immunome Inc. IMNM ██% $2.10B x 3.6x
Imunon, Inc. IMNN ██% $7M x 2.2x
Immuron Ltd IMRN ██% $9M x x
Immuneering Corp IMRX ██% $285M x 1.4x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $193M x 1.3x
Integrated Biopharma Inc INBP ██% $6M x 0.3x
Indaptus Therapeutics, Inc. INDP ██% $510M x 408.4x
Indivior Pharmaceuticals, Inc. INDV ██% $4.70B 18.7x x
Inmed Pharmaceuticals Inc. INM ██% $5M x 0.7x
Inovio Pharmaceuticals, Inc. INO ██% $91M x 15.1x
Insmed Inc INSM ██% $21.32B x 30.2x
Inhibitor Therapeutics, Inc. INTI ██% $15M x x
Innoviva, Inc. INVA ██% $1.67B 3.3x 1.3x
Io Biotech, Inc. IOBT ██% $540K x 0.6x
Io Biotech, Inc. IOBTQ ██% $420K x 0.5x
Ionis Pharmaceuticals Inc IONS ██% $12.33B x 25.1x
Opus Genetics, Inc. IRD ██% $335M x x
Disc Medicine, Inc. IRON ██% $2.68B x 3.9x
Ironwood Pharmaceuticals Inc IRWD ██% $579M 5.7x x
International Stem Cell Corp ISCO ██% $1M x x
Iterum Therapeutics Plc ITRM ██% $1M x x
Inventiva S.A. IVA ██% $834M x x
Incannex Healthcare Inc. IXHL ██% $44M x 0.6x
Jaguar Health, Inc. JAGX ██% $2M x x
Janux Therapeutics, Inc. JANX ██% $861M x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $14.05B 476.3x 3.1x
Jade Biosciences, Inc. JBIO ██% $1.03B x 3.5x
Johnson & Johnson JNJ ██% $564.12B 26.8x 7.0x
Jupiter Neurosciences, Inc. JUNS ██% $10M x x
Kala Bio, Inc. KALA ██% $53M x 4.9x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.38B x x
Kairos Pharma, Ltd. KAPA ██% $10M x 1.8x
Kaya Holdings, Inc. KAYS ██% $9M x x
Kamada Ltd KMDA ██% $419M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $4.15B 56.8x 6.9x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $212M x x
Keros Therapeutics, Inc. KROS ██% $205M x 0.7x
Korro Bio, Inc. KRRO ██% $159M x 1.3x
Pasithea Therapeutics Corp. KTTA ██% $17M x 0.3x
Kura Oncology, Inc. KURA ██% $849M x 7.9x
Kyntra Bio, Inc. KYNB ██% $28M 0.2x x
Kezar Life Sciences, Inc. KZR ██% $54M x 0.8x
Lb Pharmaceuticals Inc LBRX ██% $862M x 2.3x
Legend Biotech Corp LEGN ██% $6.23B x x
Lexaria Bioscience Corp. LEXX ██% $15M x 2.3x
Lifecore Biomedical, Inc. \De\ LFCR ██% $207M x x
Lifevantage Corp LFVN ██% $76M 9.7x 2.3x
Ligand Pharmaceuticals Inc LGND ██% $5.27B 34.3x 5.3x
Longeveron Inc. LGVN ██% $27M x 1.7x
Lianbio LIANY ██% $12M x 0.1x
Lftd Partners Inc. LIFD ██% $2M x 0.3x
Lipella Pharmaceuticals Inc. LIPO ██% $250K x 0.2x
Lite Strategy, Inc. LITS ██% $32M x 0.6x
Lixte Biotechnology Holdings, Inc. LIXT ██% $121M x 15.2x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Lakefront Biotherapeutics Nv LKFT ██% $1.87B x x
Eli Lilly & Co LLY ██% $994.68B 39.4x 31.9x
Lunai Bioworks Inc. LNAI ██% $18M x x
Lipocine Inc. LPCN ██% $17M x 0.8x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $6.06B 271.8x 55.8x
Larimar Therapeutics, Inc. LRMR ██% $368M x 2.3x
Lisata Therapeutics, Inc. LSTA ██% $32M x 2.9x
Lantern Pharma Inc. LTRN ██% $50M x 14.4x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $868M x 4.3x
Lyell Immunopharma, Inc. LYEL ██% $292M x 1.1x
Maia Biotechnology, Inc. MAIA ██% $80M x 2.9x
Mustang Bio, Inc. MBIO ██% $6M x 0.6x
Moleculin Biotech, Inc. MBRX ██% $15M x 1.0x
Mbx Biosciences, Inc. MBX ██% $1.98B x 4.5x
Seres Therapeutics, Inc. MCRB ██% $62M x 2.3x
Medicus Pharma Ltd. MDCX ██% $20M x 15.0x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $11.52B x 21.2x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $252M x 11.9x
Mira Pharmaceuticals, Inc. MIRA ██% $41M x 4.4x
Mirum Pharmaceuticals, Inc. MIRM ██% $6.19B x 25.5x
Milestone Pharmaceuticals Inc. MIST ██% $152M x 4.2x
Moonlake Immunotherapeutics MLTX ██% $1.37B x 5.4x
Mineralys Therapeutics, Inc. MLYS ██% $1.98B x 3.1x
Mannkind Corp MNKD ██% $1.21B x x
Medicinova Inc MNOV ██% $66M x 1.7x
Monopar Therapeutics MNPR ██% $418M x 3.1x
Maplight Therapeutics, Inc. MPLT ██% $1.32B x 3.3x
Mereo Biopharma Group Plc MREO ██% $47M x 1.4x
Merck & Co., Inc. MRK ██% $284.70B 31.9x 6.2x
Marker Therapeutics, Inc. MRKR ██% $23M x 1.6x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.85B x 8.7x
Matinas Biopharma Holdings, Inc. MTNB ██% $5M x 1.5x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $9M x 0.9x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.52B x 5.3x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $353M 17.7x 2.1x
Novabridge Biosciences NBP ██% $175M x 0.7x
Nanobiotix S.A. NBTX ██% $1.49B x x
Stablecoin Development Corp NBY ██% $37M x x
Newcelx Ltd. NCEL ██% $17M x 31.0x
Nucana Plc NCNA ██% $7M x x
Minerva Neurosciences, Inc. NERV ██% $192M x x
Neuphoria Therapeutics Inc. NEUP ██% $23M x 0.8x
Neurogene Inc. NGNE ██% $478M x 2.0x
Nika Pharmaceuticals, Inc NIKA ██% $535M x x
Nektar Therapeutics NKTR ██% $2.04B x 3.5x
Nkarta, Inc. NKTX ██% $195M x 0.7x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $29M x 3.2x
Nurix Therapeutics, Inc. NRIX ██% $1.77B x 3.7x
Neurosense Therapeutics Ltd. NRSN ██% $25M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $174M x x
Neonc Technologies Holdings, Inc. NTHI ██% $126M x x
Nuvation Bio Inc. NUVB ██% $1.81B x 5.7x
Nuvalent, Inc. NUVL ██% $9.71B x 8.3x
Nuvectis Pharma, Inc. NVCT ██% $317M x 22.3x
Novartis Ag NVS ██% $288.00B x x
Northwest Biotherapeutics Inc NWBO ██% $305M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $7M x 0.3x
Nexentis Technologies Inc. NXTS ██% $4M x 0.3x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.96B x 3.4x
Oragenics Inc OGEN ██% $3M x 0.4x
Organigram Global Inc. OGI ██% $144M x x
Organon & Co. OGN ██% $3.53B 14.4x 3.9x
Onkure Therapeutics, Inc. OKUR ██% $172M x 0.9x
Olema Pharmaceuticals, Inc. OLMA ██% $803M x 1.7x
Omeros Corp OMER ██% $683M 7.9x x
Beone Medicines Ltd. ONC ██% $27.38B 53.4x 5.8x
Onconetix, Inc. ONCO ██% $4M x 0.3x
Oncolytics Biotech Inc ONCY ██% $111M x x
Opko Health, Inc. OPK ██% $1.07B x 0.9x
Organogenesis Holdings Inc. ORGO ██% $309M 113.6x 1.3x
Orgenesis Inc. ORGS ██% $3M x x
Oric Pharmaceuticals, Inc. ORIC ██% $860M x 2.1x
Oruka Therapeutics, Inc. ORKA ██% $4.26B x 8.8x
Oramed Pharmaceuticals Inc. ORMP ██% $154M 1.4x 0.7x
Os Therapies Inc OSTX ██% $79M x x
Oncotelic Therapeutics, Inc. OTLC ██% $18M x 0.1x
Ovid Therapeutics Inc. OVID ██% $440M x 2.2x
One World Products, Inc. OWPC ██% $520K x x
Phibro Animal Health Corp PAHC ██% $1.29B 13.6x 3.6x
Prestige Consumer Healthcare Inc. PBH ██% $2.30B 12.1x 1.2x
Psyence Biomedical Ltd. PBM ██% $7M x x
Puma Biotechnology, Inc. PBYI ██% $365M 15.0x 2.8x
Pacira Biosciences, Inc. PCRX ██% $897M 174.6x 1.4x
Processa Pharmaceuticals, Inc. PCSA ██% $6M x 2.2x
Procyon Corp PCYN ██% $2M x 0.7x
Pds Biotechnology Corp PDSB ██% $51M x 13.2x
Pepgen Inc. PEPG ██% $110M x 0.8x
Pfizer Inc PFE ██% $148.19B 19.8x 1.7x
Precigen, Inc. PGEN ██% $1.69B x 83.6x
Phathom Pharmaceuticals, Inc. PHAT ██% $829M x x
Phio Pharmaceuticals Corp. PHIO ██% $12M x 0.8x
Pharvaris N.V. PHVS ██% $2.20B x x
Protokinetix, Inc. PKTX ██% $2M x 8.1x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $74M x 0.5x
Polomar Health Services, Inc. PMHS ██% $3M x x
Promis Neurosciences Inc. PMN ██% $91M x 1.5x
Pmv Pharmaceuticals, Inc. PMVP ██% $58M x 0.7x
Purple Biotech Ltd. PPBT ██% $2M x x
Propanc Biopharma, Inc. PPCB ██% $4M x 0.5x
Praxis Precision Medicines, Inc. PRAX ██% $7.17B x 5.1x
Prf Technologies Ltd. PRFX ██% $2M x 0.2x
Perrigo Co Plc PRGO ██% $1.44B x 0.6x
Prelude Therapeutics Inc PRLD ██% $347M x 5.8x
Prophase Labs, Inc. PRPH ██% $1M x 0.2x
Proqr Therapeutics N.V. PRQR ██% $160M x x
Prothena Corp Public Ltd Co PRTA ██% $440M x 1.4x
Ptc Therapeutics, Inc. PTCT ██% $6.07B x x
Protagonist Therapeutics, Inc PTGX ██% $7.18B x 11.0x
Protagenic Therapeutics, Inc.\New PTIX ██% $780K x x
Palatin Technologies Inc PTN ██% $21M x 2.0x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $250K 0.1x 0.1x
Pulmatrix, Inc. PULM ██% $5M x 1.5x
Provectus Biopharmaceuticals, Inc. PVCT ██% $26M x x
Palvella Therapeutics, Inc. PVLA ██% $1.58B x 6.8x
Pyxis Oncology, Inc. PYXS ██% $110M x 3.5x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $9M x 1.0x
Quantum Biopharma Ltd. QNTM ██% $23M x x
Q32 Bio Inc. QTTB ██% $225M 6.8x 4.9x
Quantum Cyber N.V. QUCY ██% $44M x 9.6x
Uniqure N.V. QURE ██% $1.70B x 11.4x
Radiopharm Theranostics Ltd RADX ██% $35M x x
Rani Therapeutics Holdings, Inc. RANI ██% $109M x 3.8x
Rapport Therapeutics, Inc. RAPP ██% $1.84B x 3.9x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.44B x x
Rocket Pharmaceuticals, Inc. RCKT ██% $306M x 1.3x
Arcus Biosciences, Inc. RCUS ██% $2.96B x 5.6x
Dr Reddys Laboratories Ltd RDY ██% $11.10B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $63.52B 14.4x 2.0x
Revelation Biosciences, Inc. REVB ██% $4M x 0.3x
Rafael Holdings, Inc. RFL ██% $130M x 1.7x
Regen Biopharma Inc RGBP ██% $50K x x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $598M 1.6x 1.5x
Rocket One Inc. RKTO ██% $26M x 6.3x
Relmada Therapeutics, Inc. RLMD ██% $697M x 3.2x
Rallybio Corp RLYB ██% $84M x 1.7x
Retrieve Medical Holdings, Inc. RMHI ██% $24M x x
Rockwell Medical, Inc. RMTI ██% $27M x 0.8x
Avidity Biosciences, Inc. RNA ██% $206M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $258M x x
Transcode Therapeutics, Inc. RNAZ ██% $5M x 4.1x
Rein Therapeutics, Inc. RNTX ██% $81M x 7.0x
Renovorx, Inc. RNXT ██% $40M x 3.5x
Roivant Sciences Ltd. ROIV ██% $21.91B x 4.8x
Royalty Pharma Plc RPRX ██% $31.22B 37.7x 4.5x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $8M x 0.4x
Rhythm Pharmaceuticals, Inc. RYTM ██% $6.14B x 50.0x
Rezolute, Inc. RZLT ██% $440M x 3.8x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $3M x 0.2x
Scienture Holdings, Inc. SCNX ██% $16M x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $610K x x
Scynexis Inc SCYX ██% $325M x 7.9x
Stablecoin Development Corp SDEV ██% $30M 0.1x 0.2x
Schrodinger, Inc. SDGR ██% $1.10B x 3.5x
Septerna, Inc. SEPN ██% $1.58B x 4.2x
Serina Therapeutics, Inc. SER ██% $31M x 1.7x
Sagimet Biosciences Inc. SGMT ██% $389M x 3.8x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $2M x 0.7x
Siga Technologies Inc SIGA ██% $308M 15.2x 2.0x
Silo Pharma, Inc. SILO ██% $7M x 1.2x
Sionna Therapeutics, Inc. SION ██% $1.57B x 5.4x
Skinvisible, Inc. SKVI ██% $1M x x
Skye Bioscience, Inc. SKYE ██% $25M x 2.8x
Sol-Gel Technologies Ltd. SLGL ██% $236M x 10.4x
Silence Therapeutics Plc SLN ██% $321M x 6.5x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.74B 28.6x 5.5x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $1.37B x 12.7x
Summit Therapeutics Inc. SMMT ██% $10.77B x 19.7x
Semnur Pharmaceuticals, Inc. SMNR ██% $207M x x
Syndax Pharmaceuticals Inc SNDX ██% $1.70B x 40.9x
Soligenix, Inc. SNGX ██% $6M x 2.0x
Sibannac, Inc. SNNC ██% $2M x x
Sensei Biotherapeutics, Inc. SNSE ██% $19M x x
Sanofi SNY ██% $105.45B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $130M x 3.7x
Scisparc Ltd. SPRC ██% $5M x x
Spero Therapeutics, Inc. SPRO ██% $124M 8.1x 2.3x
Ars Pharmaceuticals, Inc. SPRY ██% $963M x 15.7x
Sarepta Therapeutics, Inc. SRPT ██% $1.67B 25.6x 1.1x
Stoke Therapeutics, Inc. STOK ██% $1.81B x 4.6x
Shattuck Labs, Inc. STTK ██% $444M x 4.6x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.53B x 2.4x
Savara Inc SVRA ██% $1.09B x 6.2x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M x 0.8x
Synlogic, Inc. SYBX ██% $8M x 0.7x
Spyre Therapeutics, Inc. SYRE ██% $6.58B x 9.8x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $48.74B x x
Theravance Biopharma, Inc. TBPH ██% $856M 7.5x 2.9x
Alaunos Therapeutics, Inc. TCRT ██% $5M x 4.1x
Telomir Pharmaceuticals, Inc. TELO ██% $88M x 17.7x
Tenax Therapeutics, Inc. TENX ██% $306M x 2.7x
Terns Pharmaceuticals, Inc. TERN ██% $6.12B x 6.1x
Teva Pharmaceutical Industries Ltd TEVA ██% $37.73B 24.1x 4.6x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $7.83B 17.0x 13.4x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $50M x 2.7x
Telix Pharmaceuticals Ltd TLX ██% $3.43B x x
Tango Therapeutics, Inc. TNGX ██% $5.19B x 13.3x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $190M x 0.8x
Theriva Biologics, Inc. TOVX ██% $12M x 0.8x
Tempest Therapeutics, Inc. TPST ██% $18M x 22.0x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $254M x 0.9x
Trevi Therapeutics, Inc. TRVI ██% $2.07B x 12.0x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Turn Therapeutics Inc. TTRX ██% $179M x 29.3x
Tvardi Therapeutics, Inc. TVRD ██% $25M x 1.8x
Travere Therapeutics, Inc. TVTX ██% $5.05B x 51.2x
Therapeuticsmd, Inc. TXMD ██% $26M 146.8x 1.0x
Tyra Biosciences, Inc. TYRA ██% $1.72B x 4.4x
Unicycive Therapeutics, Inc. UNCY ██% $179M x 4.8x
Upstream Bio, Inc. UPB ██% $327M x 1.1x
Urogen Pharma Ltd. URGN ██% $1.59B x x
United Therapeutics Corp UTHR ██% $23.44B 18.2x 4.0x
Vaccinex, Inc. VCNX ██% $3M x x
Vera Therapeutics, Inc. VERA ██% $2.51B x 5.0x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Sb Technology Holdings, Inc. VGLS ██% $420K x x
Sb Technology Holdings, Inc. VGLSD ██% $520K x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.55B x 7.1x
Vanda Pharmaceuticals Inc. VNDA ██% $355M x 1.3x
Verrica Pharmaceuticals Inc. VRCA ██% $103M x 6.4x
Viridian Therapeutics, Inc.\De VRDN ██% $1.68B x 2.6x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $116.26B 26.8x 6.0x
Verastem, Inc. VSTM ██% $368M x 4.5x
Vistagen Therapeutics, Inc. VTGN ██% $26M x 0.7x
Viatris Inc VTRS ██% $18.16B x 1.2x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $22M x 0.9x
Whitehawk Therapeutics, Inc. WHWK ██% $203M x 1.8x
Wave Life Sciences Ltd. WVE ██% $1.16B x 2.3x
Xenetic Biosciences, Inc. XBIO ██% $7M x 1.0x
Xbiotech Inc. XBIT ██% $72M x 0.5x
Exicure, Inc. XCUR ██% $15M x 6.9x
Xenon Pharmaceuticals Inc. XENE ██% $5.19B x 3.9x
Xeris Biopharma Holdings, Inc. XERS ██% $1.22B 101.2x 93.4x
Xilio Therapeutics, Inc. XLO ██% $55M x 0.8x
Xencor Inc XNCR ██% $961M x 1.9x
Xoma Royalty Corp XOMA ██% $741M 21.9x 8.0x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $6M x x
Zenas Biopharma, Inc. ZBIO ██% $1.16B x 3.5x
Zai Lab Ltd ZLAB ██% $2.01B x 3.0x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $260M x 1.4x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $33.45B 12.7x 10.4x
Zevra Therapeutics, Inc. ZVRA ██% $744M 6.0x 3.6x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Immuneering Corp Stock Forecast

How accurate are Immuneering Corp stock predictions?

Our AI model shows a 3% Spearman correlation coefficient for IMRX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Immuneering Corp stock price forecasts?

Our analysis considers Immuneering Corp's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Immuneering Corp a good investment in 2025?

Based on our AI analysis, Immuneering Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Immuneering Corp forecasts updated?

Immuneering Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Immuneering Corp?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...